Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company HealOr Ltd.
DescriptionTopical formulation of protein kinase C (PKC) modulating agents
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationWounds
Indication DetailsTreat chronic wounds
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today